Clinicopathological characteristics associated with BRAFK601Eand BRAFL597mutations in melanoma-Reference-Cited by-同舟云学术

Clinicopathological characteristics associated with BRAFK601Eand BRAFL597mutations in melanoma

Published:2016-01-17 Issue:2 Volume:29 Page:222-228
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Voskoboynik Mark¹²^ORCID,Mar Victoria²³⁴,Mailer Sonia¹,Colebatch Andrew¹,Fennessy Anne¹,Logan Aleksandra¹,Hewitt Chelsee¹,Cebon Jonathon⁵,Kelly John²,McArthur Grant¹⁶

Affiliation:

1. Peter MacCallum Cancer Centre; East Melbourne Vic. Australia

2. Victorian Melanoma Service; Alfred Hospital; Prahran Melbourne Vic. Australia

3. Skin and Cancer Foundation; Melbourne Vic. Australia

4. Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Vic. Australia

5. School of Cancer Medicine; La Trobe University; Olivia Newton-John Cancer Research Institute; Heidelberg Vic. Australia

6. Melbourne University; Parkville Vic. Australia

Funder

Melanoma Research Alliance

Melbourne Melanoma Project (MMP)

La Trobe University

Victorian State Government Operational Infrastructure Support Program

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12450/fullpdf

Reference24 articles.

1. Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma;Bowyer;Melanoma Res.,2014

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

3. Distinct sets of genetic alterations in melanoma;Curtin;N. Engl. J. Med.,2005

4. BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors;Dahlman;Cancer Discov.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort;JCO Precision Oncology;2022-11

2. Targeted Therapy for Melanomas Without BRAF V600 Mutations;Current Treatment Options in Oncology;2022-04-05

3. Acetylation-dependent regulation of BRAF oncogenic function;Cell Reports;2022-01

4. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens;Scientific Reports;2021-04-27

5. Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib;Journal of Cancer;2021